FDA Enforcement Actions and Safety Concerns In September 2025, the FDA issued over 50 warning letters to compounders marketing GLP-1 products as generic equivalents to FDA-approved drugs
Appl Sci 11(2):575 Popat A (2012) Adsorption and release of biocides with mesoporous silica nanoparticles
Now we bake, bought a new face, I know, I know, before we all lose it
Currently, only one in four employers offer insurance coverage for GLP-1 drugs for weight managementwith variability in ease of access due to step therapy and prior authorization requirementswhile the majority of employers cover this class of medications for diabetes
By regulating mitochondrial TML availability, SLC25A45 links environmental stressors such as cold exposure and fasting to adaptive fuel switching toward fatty acid oxidation, thereby optimizing mitochondrial energetics and metabolic resilience
Shah, U